Follow
Kenward Vong
Title
Cited by
Cited by
Year
In vivo gold complex catalysis within live mice
K Tsubokura, KKH Vong, AR Pradipta, A Ogura, S Urano, T Tahara, ...
Angewandte Chemie International Edition 56 (13), 3579-3584, 2017
1562017
Biocompatibility and therapeutic potential of glycosylated albumin artificial metalloenzymes
S Eda, I Nasibullin, K Vong, N Kudo, M Yoshida, A Kurbangalieva, ...
Nature Catalysis 2 (9), 780-792, 2019
1212019
An artificial metalloenzyme biosensor can detect ethylene gas in fruits and Arabidopsis leaves
K Vong, S Eda, Y Kadota, I Nasibullin, T Wakatake, S Yokoshima, ...
Nature communications 10 (1), 1-15, 2019
722019
Synthesis and use of sulfonamide-, sulfoxide-, or sulfone-containing aminoglycoside–CoA bisubstrates as mechanistic probes for aminoglycoside N-6′-acetyltransferase
F Gao, X Yan, O Zahr, A Larsen, K Vong, K Auclair
Bioorganic & medicinal chemistry letters 18 (20), 5518-5522, 2008
552008
Prodrug Activation by Gold Artificial Metalloenzyme‐Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination
TC Chang, K Vong, T Yamamoto, K Tanaka
Angewandte Chemie International Edition 60 (22), 12446-12454, 2021
492021
Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization
K Vong, T Yamamoto, T Chang, K Tanaka
Chemical Science 11 (40), 10928-10933, 2020
442020
A viable strategy for screening the effects of glycan heterogeneity on target organ adhesion and biodistribution in live mice
A Ogura, S Urano, T Tahara, S Nozaki, R Sibgatullina, K Vong, T Suzuki, ...
Chemical Communications 54 (63), 8693-8696, 2018
392018
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity
TO Akinnusi, K Vong, K Auclair
Bioorganic & medicinal chemistry 19 (8), 2696-2706, 2011
392011
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression
I Nasibullin, I Smirnov, P Ahmadi, K Vong, A Kurbangalieva, K Tanaka
Nature Communications 13 (1), 1-12, 2022
382022
Inhibitors of aminoglycoside resistance activated in cells
K Vong, IS Tam, X Yan, K Auclair
ACS chemical biology 7 (3), 470-475, 2012
362012
2‐Benzoylpyridine Ligand Complexation with Gold Critical for Propargyl Ester‐Based Protein Labeling
Y Lin, K Vong, K Matsuoka, K Tanaka
Chemistry–A European Journal 24 (42), 10595-10600, 2018
322018
Understanding and overcoming aminoglycoside resistance caused by N-6′-acetyltransferase
K Vong, K Auclair
MedChemComm 3 (4), 397-407, 2012
302012
Propargyl‐Assisted Selective Amidation Applied in C‐terminal Glycine Peptide Conjugation
KKH Vong, S Maeda, K Tanaka
Chemistry–A European Journal 22 (52), 18865-18872, 2016
272016
Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase
E Awuah, E Ma, A Hoegl, K Vong, E Habib, K Auclair
Bioorganic & medicinal chemistry 22 (12), 3083-3090, 2014
242014
Artificial glycoproteins as a Scaffold for targeted drug therapy
K Vong, T Yamamoto, K Tanaka
Small 16 (27), 1906890, 2020
202020
Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy
K Vong, T Tahara, S Urano, I Nasibullin, K Tsubokura, Y Nakao, ...
Science Advances 7 (17), eabg4038, 2021
182021
Exploring and Adapting the Molecular Selectivity of Artificial Metalloenzymes
K Vong, I Nasibullin, K Tanaka
Bulletin of the Chemical Society of Japan 94 (2), 382-396, 2021
172021
Unlocking the therapeutic potential of artificial metalloenzymes
K Tanaka, K Vong
Proceedings of the Japan Academy, Series B 96 (3), 79-94, 2020
152020
The journey to in vivo synthetic chemistry: from azaelectrocyclization to artificial metalloenzymes
K Tanaka, K Vong
Bulletin of the Chemical Society of Japan 93 (11), 1275-1286, 2020
132020
Cancer cell targeting driven by selective polyamine reactivity with glycine propargyl esters
KKH Vong, K Tsubokura, Y Nakao, T Tanei, S Noguchi, S Kitazume, ...
Chemical Communications 53 (60), 8403-8406, 2017
132017
The system can't perform the operation now. Try again later.
Articles 1–20